Altre lingue PanGen Biotech Inc.

Azioni

A222110

KR7222110009

Prezzo di chiusura Korea S.E. Altri mercati azionari 00:00:00 05/07/2024			Variaz. 5gg	Var. 1 gen.
4.760 ^KRW	-0,52%		-4,23%	-30,81%

2023

PanGen Biotech Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2023

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

PanGen Biotech Inc. agreed to acquire PANACEA Inc. from Invites Ventures Co., Ltd., and others	21/06
PanGen Biotech Inc. announced that it has received KRW 3.999986631 billion in funding from CrystalGenomics Invites Co., LTD., Huons Co., Ltd., Hwail Pharmaceutical Co.,Ltd.	27/03
PanGen Biotech Inc. announced that it expects to receive KRW 3.999986631 billion in funding from CrystalGenomics Invites Co., LTD., Huons Co., Ltd., Hwail Pharmaceutical Co.,Ltd.	18/03
PanGen Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
PanGen Biotech Inc. announced that it has received KRW 3.2 billion in funding from Eugene Investment & Securities Co.,Ltd., Samsung Securities Co., Ltd.	20/04/23
PanGen Biotech Inc. announced that it expects to receive KRW 3.2 billion in funding from Eugene Investment & Securities Co.,Ltd., Samsung Securities Co., Ltd.	18/04/23
CrystalGenomics, Inc. agreed to acquire 20.43% stake in PanGen Biotech Inc. from the group of shareholders for approximately KRW24 billion.	22/11/22
PanGen Biotech Inc. announced that it has received KRW 9.99998571 billion in funding from Huons Co., Ltd. and another investor	11/06/21
PanGen Biotech Inc. announced that it expects to receive KRW 9.99998571 billion in funding from Huons Co., Ltd., and another investor	03/06/21
Huons Lab Forms Partnership with Pangen Biotech to Co-Develop Human Genetic Recombinant Hyaluronidase	16/12/19
PanGen Biotech Inc.(KOSDAQ:A222110) dropped from S&P Global BMI Index	23/09/19
CCM Duopharma Biotech Berhad completed the acquisition of 8.4% stake in PanGen Biotech Inc. from Chemical Company of Malaysia Berhad.	29/06/18
CCM Duopharma Biotech Berhad entered into agreement to acquire PanGen Biotech Inc. from Chemical Company of Malaysia Berhad for KRW 16.4 billion.	13/04/18
Chemical Companies In Talks To Sell Non Core Assets	02/03/18
PanGen Biotech Inc. announced that it has received KRW 18 billion in funding	21/02/18
PanGen Biotech Inc. announced that it expects to receive KRW 18 billion in funding	19/02/18
PanGen Biotech Inc.(KOSDAQ:A222110) added to S&P Global BMI Index	19/09/16
PanGen Biotech Inc. has completed an IPO in the amount of KRW 27.23 billion.	09/03/16
PanGen Biotech Inc. has filed an IPO in the amount of KRW 18.75 billion.	22/01/16
PanGen Biotech Inc. has withdrawn its IPO in the amount of KRW 35.40 billion.	24/11/15

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue PanGen Biotech Inc.

Azioni

A222110

KR7222110009

Altre lingue

Filtri